Disposables Help Drive Operational Excellence in Pharmaceutical and Biotech Manufacturing
By Janice Abel and John Blanchard, ARC Advisory Group
Biotechnology and pharmaceutical manufacturers have been looking for ways to improve operations, changeovers, and quality, and reduce costs. Depending upon the scale and specifics of the process and the automation requirements - disposable bags and equipment can often improve manufacturing efficiencies and reduce capital costs.
For these reasons, the industry has seen rapid adoption of single-use or disposable technologies over the past five years - particularly for clinical and smaller scale production applications. Future applications will also include production of vaccines and personalized medicines. By improving product quality, increasing efficiencies and yields, and reducing waste - disposable bags and equipment can help improve overall operational excellence, a strategic objective for virtually all of today's biopharm manufacturers. Just as important, it can also reduce the new facility costs and product time-to-market.
Disposable technologies also present opportunities for automation suppliers to work more closely with OEMs to develop and offer validation-ready templates or protocols and modular equipment control strategies that further simplify and minimize validation time and cost. Automation suppliers can justify the upfront investment in this joint design effort with the high potential it creates for repeat business or annuity.
ARC clients can view the complete report at Disposables Help Drive Operational Excellence in Pharmaceutical and Biotech Manufacturing
If you would like to buy this report or obtain information about how to become a client, please contact [email protected]
Posted at 12:00 AM by Steve Clouther | Permalink | Email this Post | Comments (0)